SCHEMBL583784

SCHEMBL583784

COc1ccc(Cn2ncc3c(Nc4cccc(OC)c4)c(C=O)cnc32)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.49
MAPT P10636 7/20 0.49
LMNA P02545 5/20 0.49
HPGD P15428 2/20 0.49
ALOX15 P16050 1/20 0.49
NPSR1 Q6W5P4 1/20 0.49
HSD17B10 Q99714 1/20 0.49
PKM P14618 1/20 0.49
SMN1; SMN2 Q16637 2/20 0.48
PDE4B Q07343 3/20 0.44
EGFR P00533 1/20 0.43
ERBB2 P04626 1/20 0.43
POLB P06746 2/20 0.43
MAPK1 P28482 2/20 0.43
HTT P42858 1/20 0.43
USP2 O75604 2/20 0.42
CYP1A2 P05177 2/20 0.42
CYP3A4 P08684 2/20 0.42
CYP2C9 P11712 2/20 0.42
CASP1 P29466 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL583341 0.88 PDE4B (0.52) ALDH1A1MAPTHPGDNPSR1HSD17B10
SCHEMBL583561 0.88 MAPT (0.47) ALDH1A1MAPTLMNAHPGDALOX15
SCHEMBL583562 0.88 MAPT (0.47) ALDH1A1MAPTLMNAHPGDALOX15
SCHEMBL582469 0.85 PDE4B (0.54) ALDH1A1MAPTLMNAHPGDALOX15
SCHEMBL15555724 0.84 LMNA (0.50) ALDH1A1MAPTLMNAHPGDALOX15
SCHEMBL582892 0.82 PDE4B (0.70) ALDH1A1MAPTNPSR1PKMSMN1; SMN2
SCHEMBL1135009 0.82 LMNA (0.48) ALDH1A1MAPTLMNAHPGDALOX15
SCHEMBL583294 0.81 PDE4B (0.50) ALDH1A1MAPTLMNAHPGDALOX15
SCHEMBL1135057 0.79 LMNA (0.52) ALDH1A1MAPTLMNAHPGDALOX15
SCHEMBL582731 0.77 PDE4B (0.47) ALDH1A1MAPTLMNAHPGDALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8420666-B2 Pyrazolo (3, 4-B) pyridine derivatives as phosphodiesterase inhibitors RANBAXY LABORATORIES LIMITED (IN) 2013-04-16 US disclosed
EP-2124944-B1 Pyrazolo[3,4-b]pyridine derivatives as phosphodiesterase inhibitors RANBAXY LAB LTD (IN) 2012-02-15 EP disclosed
US-20100292196-A1 PYRAZOLO (3, 4-B) PYRIDINE DERIVATIVES AS PHOSPHODIESTERASE INHIBITORS RANBAXY LABORATORIES LIMITED (IN) 2010-11-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100292196-A1 PYRAZOLO (3, 4-B) PYRIDINE DERIVATIVES AS PHOSPHODIESTERASE INHIBITORS PDE3B, PDE4A, PDE3A ALDH1A1 1007/4885MAPT 2607/4885LMNA 4852/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.